Brookstone Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$716K Sell
16,783
-233,448
-93% -$12.7M 0.01% 817
2026
Q1
$15.7M Buy
250,231
+67,034
+37% +$5.36M 0.18% 142
2025
Q4
$17.5M Buy
183,197
+53,876
+42% +$5.28M 0.2% 122
2025
Q3
$12.6M Buy
129,321
+13,906
+12% +$1.44M 0.15% 166
2025
Q2
$12.4M Buy
115,415
+2,454
+2% +$248K 0.16% 153
2025
Q1
$11.4M Buy
112,961
+7,101
+7% +$715K 0.16% 155
2024
Q4
$9.46M Buy
105,860
+20,307
+24% +$1.79M 0.14% 184
2024
Q3
$7.17M Buy
85,553
+15,608
+22% +$1.23M 0.11% 203
2024
Q2
$5.41M Buy
69,945
+55,645
+389% +$4.07M 0.09% 219
2024
Q1
$979K Buy
14,300
+3,710
+35% +$239K 0.02% 496
2023
Q4
$612K Sell
10,590
-129
-1% -$6.89K 0.01% 557
2023
Q3
$542K Buy
10,719
+134
+1% +$7.03K 0.01% 553
2023
Q2
$553K Sell
10,585
-20,832
-66% -$1.09M 0.01% 557
2023
Q1
$1.63M Buy
31,417
+20,685
+193% +$975K 0.03% 357
2022
Q4
$497K Buy
10,732
+4
+0% +$173 0.01% 579
2022
Q3
$425K Buy
+10,728
New +$430K 0.01% 592
2015
Q4
Sell
-77
Closed -$1K 241
2015
Q3
$1K Hold
77
﹤0.01% 1785
2015
Q2
$1K Buy
+77
New +$1.38K ﹤0.01% 1934

Other funds holding BSX

Brookstone Capital Management's BSX Position: Q2 2026 in Review

Brookstone Capital Management reduced its Boston Scientific (BSX) stake by 93% in Q2 2026, selling an estimated $12.7M and leaving 16,783 shares worth $716K. The position accounts for 0.01% of the portfolio, ranked #817.

Brookstone Capital Management first reported a position in BSX in Q2 2015 and has held it in 18 quarters since. The position peaked at $17.5M in Q4 2025. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Brookstone Capital Management held 16,783 shares of Boston Scientific worth $716K as of Q2 2026.
  • Brookstone Capital Management sold 233,448 Boston Scientific shares in Q2 2026, an estimated $12.7M.
  • Boston Scientific made up 0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #817 holding.
  • Brookstone Capital Management first reported a position in Boston Scientific in Q2 2015 and has held it in 18 quarters since.
  • Brookstone Capital Management's Boston Scientific position peaked at $17.5M in Q4 2025.
  • 303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.